These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 3209253)

  • 1. Dipyridamole thallium testing: noncardiac side effects, cardiac effects, electrocardiographic changes and hemodynamic changes after dipyridamole infusion with and without exercise.
    Laarman GJ; Niemeyer MG; van der Wall EE; Verzijlbergen FJ; Go TL; Bruschke AV; Ascoop CA
    Int J Cardiol; 1988 Aug; 20(2):231-8. PubMed ID: 3209253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous low level treadmill exercise and intravenous dipyridamole stress thallium imaging.
    Casale PN; Guiney TE; Strauss HW; Boucher CA
    Am J Cardiol; 1988 Oct; 62(10 Pt 1):799-802. PubMed ID: 3421182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thallium-201 scintigraphy after dipyridamole infusion with low-level exercise. III. Clinical significance and additional diagnostic value of ST segment depression and angina pectoris during the test.
    Laarman GJ; Serruys PW; Verzijlbergen JF; Ascoop CA
    Eur Heart J; 1990 Aug; 11(8):705-11. PubMed ID: 2397734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of intravenous dipyridamole with exercise in thallium-201 myocardial perfusion scintigraphy.
    Laarman GJ; Bruschke AV; Verzijlbergen FJ; Bal ET; van der Wall EE; Ascoop CA
    Eur Heart J; 1988 Nov; 9(11):1206-14. PubMed ID: 3234412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dipyridamole-induced ST segment depression during thallium-201 imaging in patients with coronary artery disease: angiographic and hemodynamic determinants.
    Chambers CE; Brown KA
    J Am Coll Cardiol; 1988 Jul; 12(1):37-41. PubMed ID: 3379218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dipyridamole-echocardiography and thallium exercise myocardial scintigraphy in the diagnosis of obstructive coronary or microvascular disease in hypertensive patients with left ventricular hypertrophy and angina].
    Astarita C; Nicolai E; Liguori E; Gambardella S; Rumolo S; Maresca FS
    G Ital Cardiol; 1998 Sep; 28(9):996-1004. PubMed ID: 9788038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and clinical utility of combined intravenous dipyridamole/symptom-limited exercise stress test with thallium-201 imaging in patients with known or suspected coronary artery disease.
    Ignaszewski AP; McCormick LX; Heslip PG; McEwan AJ; Humen DP
    J Nucl Med; 1993 Dec; 34(12):2053-61. PubMed ID: 8254386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Thallium-201 scintigraphy after dipyridamole infusion in patients with ischemic heart disease--comparison with maximal exercise].
    Toyama T; Nishimura T; Uehara T; Shimonagata T; Hayashida K; Hamada S; Hirose Y; Itoh A; Nonogi H; Haze K
    Kaku Igaku; 1992 Feb; 29(2):193-201. PubMed ID: 1564789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of coronary artery disease by controlled coronary vasodilation with adenosine and thallium-201 scintigraphy in patients unable to exercise.
    Verani MS; Mahmarian JJ; Hixson JB; Boyce TM; Staudacher RA
    Circulation; 1990 Jul; 82(1):80-7. PubMed ID: 2364527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ST-segment depression during dipyridamole infusion, and its clinical, scintigraphic and hemodynamic correlates.
    Villanueva FS; Smith WH; Watson DD; Beller GA
    Am J Cardiol; 1992 Feb; 69(5):445-8. PubMed ID: 1736603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the severity of coronary artery disease by thallium-201 washout rate after dipyridamole infusion--a coronary hemodynamic and metabolic study.
    Tamoto S; Ishihara T; Kojima S; Hosokawa H; Ohkubo T; Ohtuji S; Fukai M; Takada K; Seki I; Ohsawa N
    Jpn Circ J; 1995 Jan; 59(1):11-22. PubMed ID: 7752441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute hemodynamic changes during intravenous dipyridamole thallium imaging early after infarction.
    Miller DD; Scott RA; Riesmeyer JS; Chaudhuri TK; Blumhardt R; Boucher CA; O'Rourke RA
    Am Heart J; 1989 Oct; 118(4):686-94. PubMed ID: 2801475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative comparison of thallium-201 scintigraphy after exercise and dipyridamole in coronary artery disease.
    Varma SK; Watson DD; Beller GA
    Am J Cardiol; 1989 Oct; 64(14):871-7. PubMed ID: 2801554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and diagnostic accuracy of dipyridamole-thallium imaging in the elderly.
    Lam JY; Chaitman BR; Glaenzer M; Byers S; Fite J; Shah Y; Goodgold H; Samuels L
    J Am Coll Cardiol; 1988 Mar; 11(3):585-9. PubMed ID: 3343462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on intravenous dipyridamole cardiac imaging in the assessment of ischemic heart disease.
    Younis LT; Chaitman BR
    Clin Cardiol; 1990 Jan; 13(1):3-10. PubMed ID: 2404645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of nifedipine on dipyridamole thallium-201 myocardial scintigraphy.
    Bonaduce D; Muto P; Morgano G; Canonico V; Breglio R; Salvatore M; Condorelli M
    Clin Cardiol; 1986 Jun; 9(6):285-8. PubMed ID: 3720052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamic indices of myocardial dysfunction correlate with dipyridamole thallium-201 SPECT.
    Chin BB; Moshin J; Bouchard M; Berlin JA; Araujo LI; Alavi A
    J Nucl Med; 1996 May; 37(5):723-9. PubMed ID: 8965134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonlimited exercise test combined with high-dose dipyridamole for thallium-201 myocardial single-photon emission computed tomography in coronary artery disease.
    Daou D; Le Guludec D; Faraggi M; Foult JM; Lebtahi R; Cohen-Solal A; Assayag P; Steg G
    Am J Cardiol; 1995 Oct; 76(11):753-8. PubMed ID: 7572649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Quantitative thallium myocardial tomoscintigraphy. Value of intravenous infusion of dipyridamole after negative submaximal exercise test].
    Levy M; Pornin M; Languillat N; Charles JP; Angelard T; Sarkhis A; Bayet G; Guize L; Paillard M; Ourbak P
    Arch Mal Coeur Vaiss; 1992 Feb; 85(2):187-91. PubMed ID: 1562221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients with stable chronic obstructive pulmonary disease can safely undergo intravenous dipyridamole thallium-201 imaging.
    Shaffer J; Simbartl L; Render ML; Snow E; Chaney C; Nishiyama H; Rauf GC; Wexler LF
    Am Heart J; 1998 Aug; 136(2):307-13. PubMed ID: 9704695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.